Regeneron puts finishing touches on $800M expansion project close to home

Amber Tong

Senior Editor

Regeneron is finalizing its grand plans for an expansive new campus designed to support its rapid growth bolstered by the blockbuster Eylea franchise.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

Regeneron puts finishing touches on $800M expansion project close to home

Amber Tong

Senior Editor

Unlock this article instantly by becoming a free subscriber.

Head of Regulated Labs Market Strategy

Benchling

San Francisco, CA, USA

Patient dies in Pfizer’s Phase 2 Duchenne muscular dystrophy trial

AstraZeneca pulls Covid-19 vaccine globally as the pharma sees 'no future commercial demand'

Teva’s antipsychotic asset passes Phase 3 test in schizophrenia

Exclusive: Engineered B cell therapy startup Walking Fish shuts down

Madrigal 'encouraged' by early launch progress of landmark NASH drug

Medical Affairs: The Critical Link Between Science, Physicians and Patients

Re­gen­eron puts fin­ish­ing touch­es on $800M ex­pan­sion project close to home

Senior Editor

Unlock this article instantly by becoming a free subscriber.

Benchling

San Francisco, CA, USA

Regeneron puts finishing touches on $800M expansion project close to home